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Abstract
Objectives To evaluate the feasibility of a newly proposed minimally invasive split-thickness flap design without vertical-
releasing incisions for vertical bone regeneration performed in either a simultaneous or staged approach and to analyze the
prevalence of adverse events during postoperative healing.
Materials and methods Following preparation of a split-thickness flap and bilaminar elevation of the mucosa and underlying
periosteum, the alveolar bone was exposed over the defects, vertical GBRwas performed bymeans of a titanium-reinforced high-
density polytetrafluoroethylene membrane combined with particulated autogenous bone (AP) and bovine-derived xenograft
(BDX) in 1:1 ratio. At 9 months after reconstructive surgery, vertical and horizontal hard tissue gain was evaluated based on
clinical and radiographic examination.
Results Twenty-four vertical alveolar ridge defects in 19 patients were treated with vertical GBR. In case of 6 surgical sites,
implant placement was performed at the time of the GBR (simultaneous group); in the remaining 18 surgical, sites implant
placement was performed 9 months after the ridge augmentation (staged group). After uneventful healing in 23 cases, hard tissue
fill was detected in each site. Direct clinical measurements confirmed vertical and horizontal hard tissue gain averaging 3.2 ±
1.9 mm and 6.5 ± 0.5 mm respectively, in the simultaneous group and 4.5 ± 2.2 mm and 8.7 ± 2.3 mm respectively, in the staged
group. Additional radiographic evaluation based on CBCT data sets in the staged group revealed mean vertical and horizontal
hard tissue fill of 4.2 ± 2.0 mm and 8.5 ± 2.4 mm. Radiographic volume gain was 1.1 ± 0.4 cm3.
Conclusion Vertical GBR consisting of a split-thickness flap and using titanium-reinforced non-resorbable membrane in con-
junction with a 1:1 mixture of AP+BDX may lead to a predictable vertical and horizontal hard tissue reconstruction.
Clinical relevance The used split-thickness flap design may represent a valuable approach to increase the success rate of vertical
GBR, resulting in predicable hard tissue regeneration, and favorable wound healing with low rate of membrane exposure.
Keywords Guided bone regeneration . Vertical augmentation . Split-thickness flap . Implant placement . Non-resorbable
membrane . Autogenous bone . Xenograft
Introduction
During the past decades, dental implant therapy has become a
frequently chosen solution to replace missing teeth. In order to
achieve long-term success and esthetic results, optimal
amounts of vertical and horizontal hard tissue dimension as
well as an adequate soft tissue environment are required. The
three-dimensional resorption of the alveolar ridge is one of the
most unwanted biological processes following tooth extrac-
tion; resorption is more progressive in patients with periodon-
tal disease due to unfavorable hard and soft tissue conditions
[1–3]. As a result, edentulous sites often present compromised
dimensions, and therefore, ridge augmentation may be re-
quired before or at the time of implant placement.
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Several reconstructive surgical methods are suggested in
li terature to rebuild the deficient alveolar ridge.
Transplantation of autogenous bone blocks (AB) is a well-
documented surgical approach to reconstruct three-
dimensional alveolar defects. This technique requires a rela-
tively moderate healing time of 4–6 months, but the resorption
rate of AB as well as the quality and survival of transplanted
tissues shows high individual variations [4–6]. The most fre-
quently reported surgical technique to rebuild missing alveolar
bone is guided bone regeneration (GBR), which has been
shown to deliver predictable long-term results in terms of
crestal bone stability, implying however a longer healing pe-
riod (i.e., 6–9 months) [7–9]. By using a barrier membrane, a
secluded space should be created to prevent epithelial migra-
tion into the wound and while the particulated auto- or xeno-
grafts may stabilize the blood clot and facilitate bone forma-
tion [10]. The GBR technique is feasible for both horizontal
and vertical reconstruction of edentulous sites utilizing resorb-
able or non-resorbable membranes [6, 11–13].
Vertical ridge augmentation yields less predictable treat-
ment outcomes compared with horizontal ridge augmentation
due to the fact that it requires advanced flap management and
uncompromised soft tissue coverage of the wound to protect
the grafts and to support supracrestal blood clot stabilization
[14]. It has been demonstrated that the blood and cell supply
during the healing process following ridge reconstructions
mainly originates from the periosteum [15]. The elevation of
the periosteum in order to support both revascularization and
tissue integration of supracrestally positioned grafting mate-
rials is not only surgically extremely challenging but also im-
plies a longer healing time for the regeneration process.
Numerous studies have demonstrated the advantages of rein-
forced non-resorbable membranes to achieve successful ver-
tical hard tissue reconstruction by maintaining and protecting
the space for the blood clot and the filler material and by
excluding soft tissue penetration [16].
Non-resorbable expanded polytetrafluoroethylene (e-
PTFE) membranes are accepted as the gold standard for ver-
tical GBR due to their favorable mechanical and barrier prop-
erties. Since the main rationale for GBR membrane rigidity is
to ensure space maintenance, the most commonly used e-
PTFE membranes are reinforced by titanium. In this way,
the risk for graft compression during the healing period can
be reduced over the biologically determined 9 months of
healing required for graft maturation and corticalization.
Early wound dehiscence and membrane exposure are the
main reasons for decreased treatment predictability following
the application of non-resorbable membranes during GBR
procedures. Bacterial colonization of exposed membrane sur-
faces inevitably leads to tissue inflammation and graft disin-
tegration requiring premature membrane removal before the
completion of the healing period, which leads to reduced hard
tissue formation [17].
If properly executed, the conventional full-thickness flap de-
sign with vertical and horizontal releasing incisions results in
tension-free wound closure and subsequent primary intention
wound healing; however, insufficient healing and membrane ex-
posure is a well-documented complication of this approach [18].
Apart from decreasing flap tension, the placement of incisions,
which disrupt the continuity of the periosteal layer, may nega-
tively affect periosteal blood supply. As an alternative to the
classical full-thickness flap design for vertical GBR, a split-
thickness flap approach was suggested by several authors, which
might similarly result in a tension-free wound closure but at the
same time avoiding the previously mentioned adverse events
related to full-thickness flaps [19, 20]. More recently, in order
to additionally improve the healing and to improve the predict-
ability of vertical augmentation procedures, our group proposed a
novel minimally invasive split-thickness flap design without
vertical-releasing incisions [13].
Particulated autogenous bone grafts (AP) have highly ac-
tive biological capacity and are preferred based on their
osteoinductive properties; nevertheless, they are prone to early
resorption when used alone for GBR [16]. Therefore, in order
to prolong graft stability and to minimize the amount of har-
vested autogenous bone, recent studies have suggested to
combine AP with bovine-derived xenograft (BDX). The effi-
cacy of a mixed 1:1 ratio of AP + BDX has been reported by
several authors [21–24]. BDX is the most commonly used and
researched xenogeneic material for GBR with proven
osteoconductive effect and volumetric stability [25].
According to the literature, when applying non-resorbable
membranes in combination with AP + BDX for vertical GBR,
approximately 9 months of healing is needed for proper graft
maturation and tissue integration, allowing for implant place-
ment and long-term crestal bone maintenance. In cases of
minor vertical alveolar defects with mild to moderate hard
tissue loss, primary stability of a dental implant in standard
length and width can be achieved. In such cases, a GBR ap-
proach can be used simultaneously to implant placement [26].
If the abovementioned prerequisites for implant placement are
not given, the staged approach is indicated, implying ridge
reconstruction 9 months prior to implant placement [22].
However, at present, the data on the outcomes of vertical bone
augmentation by means of GBR are still scarce and controversy
exists on the predictability of these approaches. However, at
present, it is unknown to what extent our recently described
minimally invasive split-thickness flap design without vertical-
releasing incisions [13]may lead to predictable clinical outcomes
in terms of postoperative complications and treatment outcomes.
Therefore, the aims of the present prospective case series study
were (a) to evaluate the feasibility of the proposed minimally
invasive split-thickness flap design without vertical-releasing in-
cisions for vertical bone regeneration performed in either a simul-
taneous or staged approach and (b) to record and analyze the
prevalence of adverse events during postoperative healing.
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Materials and methods
The present case series was performed in patients with ad-
vanced chronic periodontitis (grade III, stage B) [27] present-
ing localized three-dimensional alveolar ridge defects requir-
ing surgical bone augmentation to allow implant placement.
Patients underwent comprehensive periodontal treatment pri-
or to surgery, no residual pockets deeper than 3 mm were
present, full-mouth plaque score were less than 20%, and
full-mouth bleeding scores were less than 15%. Teeth were
extracted at least 6 months prior to surgery. The reasons for
tooth loss were either severe attachment and bone loss (i.e.,
attachment and bone loss reaching the apex of the teeth and/or
class III furcation involvements) or complicated perio-
endodontic lesions.
All patients were selected and treated at the Department of
Periodontology, Semmelweis University, Budapest, Hungary,
between January 2012 and June 2015.
The study protocol was approved by the Semmelweis
University Regional and Institutional Committee of Science
and Research Ethics (Approval Number 77/2011). Surgical
interventions were undertaken with the understanding
and written informed consent of each subject. The pa-
tients were treated in full accordance with ethical prin-
ciples, including the World Medical Association
Declaration of Helsinki (version 2008).
Preoperative care
Preoperatively, supra- and subgingival scaling was performed,
patients received individual oral hygiene instructions and
maintained a high level of oral hygiene throughout the whole
treatment period (full-mouth plaque score and full-mouth
bleeding score did not exceed 25%). Presurgical patients used
chlorhexidine digluconate 0.2% mouthrinse (Curasept ADS
220, Curaden AG, Kriens, Switzerland) for 2 min.
Surgical technique
The surgical approach was described in detail elsewhere [13].
Briefly, in both groups’ local anesthesia (4% articaine-
hidrocloride with 0.0001% epinephrine - Ultracain DS Forte,
Sanofi-Aventis, Paris, France), a midcrestal incision was
placed on the keratinized mucosa with no. 15 blades
(Aesculap, Braun AG, Tuttlingen, Germany). The midcrestal
incision was continued intracrevicularly at the two adjacent
teeth mesially and distally both buccally and orally with no.
15C blades. In case of posterior edentulism, the midcrestal
incision line length was two-thirds of the entire surgical area,
and one-third length was continued mesially to the neighbor-
ing two teeth. No vertical-releasing incisions were performed.
A full-thickness buccal flap was reflected with elevators up to
the MJ, followed by split-thickness mucosal flap preparation
over the mucogingival line (MJ). Subsequently, the underly-
ing periosteal layer was elevated from the bone surface. In the
simultaneous group, 3.3-mm or 4.1-mm diameter bone level
implants (Straumann AG, Basel, Switzerland) were placed in
a prosthetically predefined position using surgical guides. No
implants with 3.3-mm diameter were placed in molar posi-
tions. All implants were positioned supracrestally according
to their preplanned prosthetic positions. A single-use dispos-
able bone scraper (Safescraper, Osteogenics Biomedical,
Lubbock, TX, USA) was used to harvest AP from the lateral
surface of the adjacent alveolar ridge. Bone chips were mixed
with BDX (Bio-Oss, Geistlich AG, Wolhusen, Switzerland)
in a 1:1 ratio. The 1:1 mixture of AP + BDX was placed
laterally and supracrestally to the alveolar ridge. A non-
resorbable high-density PTFE (d-PTFE) membrane
(Cytoplast, Osteogenics Biomedical, Lubbock, USA) was
fixed with titanium pins (Frios Membrane Tacks, Dentsply,
York, USA). Double-layer suturing was performed using 4-0
horizontal mattress sutures (Supramid, Braun AG, Tuttlingen,
Germany) in order to cover the membrane with the periosteal
layer, while 5-0 horizontal mattress and non-interrupted su-
tures (Supramid, Braun AG, Tuttlingen, Germany) were uti-
lized to close the mucosal layer and to reach a tension-free
wound closure. Sutures were removed after 14 days.
In the staged group, at 9 months, a split-thickness
flap was elevated in the same way as described above.
The titanium pins and the d-PTFE membrane were re-
moved, and 3.3-mm or 4.1-mm diameter bone level im-
plants (Straumann AG, Basel, Switzerland) were placed
in a prosthetically predefined position using a surgical
template (Fig. 1a–p). Also, in this group, no implants
with 3.3-mm diameter were placed in molar positions.
The flap was closed with horizontal mattress sutures
and single interrupted sutures. Soft tissue augmentation
was performed at the time of implant placement if the
vertical dimension of the soft tissue thickness was less
than 2 mm over the inserted implants. Two months
later, in cases where less than 3-mm width of
keratinized mucosa was present, palatal epithelialized
free gingival grafts were harvested and placed. After
another 2 months, implant uncovery was performed.
In the simultaneous group, membranes and titanium
pins were removed at 9 months after the first surgery,
and the implants were only uncovered if an adequate
peri-implant soft tissue width (i.e., at least 3 mm) sur-
rounding the implants was present (Fig. 2 a–n). Soft
tissue augmentation was performed at the time of mem-
brane removal if the peri-implant soft tissue thickness
(vertical dimension) was less than 2 mm. The above
described reconstruction of keratinized tissues was per-
formed 2 months before the second-stage surgery only
in cases without an adequate width and thickness or
absence of keratinized tissue.
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Postoperative care
Postoperatively, antibiotic therapy (Penicillin with Clavulanic
acid 2 × 1000 mg/day; Augmentin Duo, GlaxoSmithKline,
Brentford, UK) and non-steroidal anti-inflammatory drugs
(Diclofenac-Sodium 4 × 50 mg/day; Cataflam, Novartis
International AG, Basel, Switzerland) were prescribed for
1 week in order to avoid infections and to decrease swelling
and pain. In case of penicillin allergy, Clindamycin (Dalacin
C, Pfizer, New York, USA) 4 × 300 mg per day was pre-
scribed. Patients were instructed to gently brush teeth
at surgical sites with a soft manual toothbrush. For
chemical plaque control, 0.2% chlorhexidine digluconate
mouthwash (Curasept ADS 220, Curaden AG, Kriens,
Switzerland) was prescribed twice a day. Mucosal su-
tures were removed 7 days, periosteal sutures 14 days
after surgery. Following suture removal, patients were
scheduled for recall visits weekly in the first month,
followed by visits every 3 months postoperatively.
Patients received fixed partial dentures 2 weeks after
implant uncovering. After delivery of the final prosthet-
ic reconstructions, patients were enrolled in a periodon-
tal maintenance program.
Clinical evaluation
Measurements were taken by a single investigator, KO,
following examiner calibration. In the simultaneous
group, direct measurements were performed by UNC-
15 probes (HU-Friedy, Chicago, IL, USA) during the
first surgery. The distance between crestal bone and
the most coronal part of the supracrestally positioned
implants (Clinical Vertical Dimension - c-VD) was re-
corded as a negative value (lack of hard tissue). Extent
c-VD was recorded at 4 aspects of each implant (ves-
tibular, oral, mesial, distal); mean values were
Fig. 1 Case presentation of patient no. 11, (case no. 13 - left mandible)
from the staged group. a Baseline CBCT scan, parasagittal section:
2 months after tooth extraction, horizontovertical alveolar defect. b
Baseline CBCT scan, frontal section: 2 months after tooth extraction,
horizontovertical alveolar defect. c Clinical view of edentulous mandible.
d Split-thickness flap preparation. e Bovine-derived xenograft (Geistlich
Bio-Oss) and particulate autogenous bone graft. f Adaptation of non-
resorbable membrane (Osteogenics Cytoplast) over the composite graft.
g Membrane fixation using titanium pins. h Double-layer suturing:
tension-free periosteal layer closure with horizontal mattress sutures. i
Mucosal layer closure with horizontal mattress and non-interrupted su-
tures. j Wound healing 2 weeks after surgery. k Postoperative CBCT
scan: 9 months after GBR parasagittal section: vertical bone gain. l
Postoperative CBCT scan: 9 months after GBR, frontal section: vertical
and horizontal bone gain. m Membrane removal at 9 months reentry. n
Optimal amount of hard tissue for implant placement. o Guided implant
placement (Straumann bone level). p Prosthetically driven implant
positioning
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calculated. The orovestibular dimension of the ridge at
the level of the most coronal part of the implant
(Clinical Horizontal Dimension - c-HD) was by defini-
tion zero. During implant recovery, c-VD and c-HD
were recorded again following membrane removal; ver-
tical and horizontal hard tissue gain was calculated
(Clinical Vertical Dimension Gain - c-VDG, Clinical
Horizontal Dimension Gain - c-HDG). In the staged
group, both direct and radiographic evaluations were
performed. c-VD and c-HD were measured directly
using by UNC-15 probes and individually fabricated
surgical stent during augmentation and implant place-
ment in the planned implant position. The distance be-
tween the surgical stent and crestal bone level was re-
corded at the time of GBR and at implant placement.
Differences were registered as c-VDG. The orovestibular
dimension of the alveolar ridge at the postopoperative
crestal bone level was by definition zero; thus, c-HDG
calculation was based on postop orovestibular dimension
at the crestal bone level.
Radiographic evaluation
Measurements were taken by a single investigator, KO, fol-
lowing examiner calibration. Intraoral radiographs,
orthopantomograms, and Cone Beam Tomography (CBCT)
scans (i-CAT, KaVo, Biberach, Germany) were taken
(120 kVp; 5 mA; 7.4 s; 0.200-mm voxel sizes; 360° rotation)
to assess the three-dimensional morphology of edentulous al-
veolar ridges at baseline prior to surgery. Further intraoral
radiographs were taken at implant loading and during recall
visits on a yearly basis. Measurements were performed in the
planned implant positions at every surgical site. In the staged
group, a second CBCT scan was taken 9 months after GBR
procedure for three-dimensional implant position planning;
thus, radiographic evaluation was performed based on
CBCT data (Radiographic Vertical Dimension - r-VD,
Radiographic Horizontal Dimension - r-HD). For alignment
of pre- and postoperative datasets, adjacent teeth were used as
an anatomical reference. Radiographic Vertical Dimension
Gain (r-VDG) and Radiographic Horizontal Dimension Gain
Fig. 2 Case presentation of patient no. 4 (case no. 5 - right mandible)
from the simultaneous group. aBaseline CBCT scan, parasagittal section:
horizontovertical alveolar defect. b Baseline CBCT scan, frontal section:
horizontovertical alveolar defect. c Clinical view of edentulous mandible.
d Split-thickness flap preparation. e Guided implant placement,
supracrestally positioned implant (Straumann bone level). f Adaptation
of non-resorbable membrane (Osteogenics Cytoplast) over the composite
graft. gMembrane fixation using titanium pins. hDouble-layer suturing. i
Postoperative intraoral X-ray. j Healed alveolar ridge 9 months after
simultaneous GBR. k Membrane removal at 9 months reentry. l, m, n
Optimal amount of hard tissue; previously placed distal implant is cov-
ered with hard tissue, additional implant placed mesially
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(r-HDG) were calculated. If more than 1 implant was placed in
the surgical area, hard tissue gain was measured in every
planned implant position, and the highest value was recorded.
Radiographic linear measurements were performed by the i-
CAT Vision software (Imaging Sciences International,
Hatfield, PA, USA). Additional 3D volumetric measurement
was performed in the staged group to evaluate the hard tissue
gain (Radiographic Volume - r-VOL). Patients with GBR
procedure and with sinus floor elevation were excluded from
3D measurement based on augmented area separation inaccu-
racy. Radiographic volume measurements were performed by
the Osirix software (Pixmeo Sarl, Geneva, Switzerland).
Statistical analysis
Comparison of hard tissue changes between the two groups
was not the aim of this study. “Horizontal and vertical dimen-
sion changes were recorded using the above described mea-
surement method and therefore, only descriptive statistics
were performed.”
Mean values and standard deviations (SDs) were
calculated.
Results
Systemically healthy, partially edentulous patients were treated at
the Department of Periodontology, Semmelweis University,
Budapest, Hungary: 24 surgical sites of 19 non-smoking subjects
were selected. Treatments were performed at 8 maxillary and 16
mandibular sites. The average age was 50.3 ± 12.9 years, 2 pa-
tients were male, and 17 patients were female (Table 1.)
In the present study, 45 Straumann bone level implants
were placed in 24 vertically augmented surgical sites. In the
simultaneous group, implant placement was performed with
simultaneous GBR (9 implants in 5 patients and 6 surgical
sites) if at least 6-mm vertical bone height was detected
coronally from the adjacent anatomical landmarks (floor of
maxillary sinus or nasal cavity, mandibular nerve). In the
staged group, implants were placed at 9 months after GBR
(36 implants in 15 patients and 18 surgical sites) in cases
where the residual vertical bone height was less than 6 mm.
One patient was represented in both groups. Patient no. 4 in
the simultaneous group is equivalent to patient no. 12 in the
staged group. This patient received a dental implant in posi-
tion no. 46 with simultaneous GBR, and after the healing
period, the patient received another dental implant into the
newly formed hard tissue in position no. 45 (Fig. 2). A total
of 4 patients (i.e., 2 patients from the simultaneous and 2
patients from the staged group) displayed a single tooth gap,
while the remaining patients had larger edentulous sites and
received more than one implant.
All GBR procedures were successful; the healing period
was uneventful in all 18 patients and 23 sites. Swelling and
pain was moderate in all cases; additional medication, such as
the prescription of systemic steroids, was not needed. Early
membrane exposure was detected in 1 surgical site. In this
particular case, the d-PTFE membrane was removed and re-
placed by a resorbable collagen membrane (Bio-Gide,
Geistlich AG, Wolhusen, Switzerland) at 6 weeks after sur-
gery. At the time of the reentry in the staged group, every
augmented site was suitable for implant placement after mem-
brane removal. The site with early membrane removal re-
ceived additional connective tissue grafting to compensate
for the loss of soft tissues.
In the simultaneous group, 5 patients with 6 surgical sites
were treated, a total of 9 implants were placed simultaneously
with the GBR procedure (Table 2). Mean c-VDG was 3.2 ±
1.9 mm, and mean c-HDG was 6.5 ± 0.5 mm. GBR proce-
dure’s success rate in the simultaneous group was 92.6%,
Table 1 Patient’s demographics
and treatment allocation Characteristic No. of subjects No. of surgical sites No. of implants No. of patients
with volume assessment
Gender
Male 2 2 2 0
Female 17 22 43 13
Mean age (y) 50.25 ± 12.90
Surgical area
Maxilla 7* 8 13 2
Mandible 13* 16 32 11
Treatment allocation
Simultaneous group 5 6 9 0
Staged group 15 18 36 13
*One patient was presented in both groups
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where a 100% success rate refers to implant surfaces fully
covered with new hard tissue. The most coronal part of the
implants was covered with newly formed hard tissue around 7
implants, representing 100% successful augmentation.
Around 1 implant, implant coverage was incomplete, a mean
postoperative c-VD of 2 mm (patient 1, implant in position
16) was recorded. In this case, the success rate (hard tissue
gain in percentage) of the augmentation was 50%.
In the staged group, 15 patients with 18 surgical sites were
treated, a total of 36 implants were placed 9 months after GBR
(Table 3). Mean c-VDG was 4.5 ± 2.2 mm, and mean c-HDG
was 8.7 ± 2.3 mm.
Additional linear radiographic measurements in the staged
group based on alignment of baseline and 9 months CBCT
scans showed lower hard tissue gain compared with direct
clinical measurements. Mean r-VDGwas 4.2 ± 2.0 mm, while
mean r-HDG was 8.5 ± 2.4 mm.
Thirteen augmented sites of 11 patients from the staged
group were suitable for 3D volumetric measurement to com-
pare the amount of the hard tissue before and 9 months after
the surgery. The main r-VOL was 1.1 ± 0.4 cm3.
In cases which required soft tissue augmentation, the rea-
son for the soft tissue deficiency either occured due to the
baseline defect or occurred due to extensive flap mobilization
Table 2 Simultaneous group
Patient no. (site no.) Age (y) Sex Arch Mean c-VDG (mm) Mean c-HDG (mm)
1 (1) 38 F Maxilla 2 6.6
2 (2) 35 M Maxilla 6.9 6.3
3 (3) 36 F Mandible 1.75 7
4 (4) 63 F Mandible 2.75 7
4 (5) 63 F Mandible 2.75 6
5 (6) 42 F Mandible 3 6
Mean 3.19 6.48
STDEV 1.88 0.46
c-VDG clinical vertical dimension gain, c-HDG clinical horizontal dimension change
Table 3 Staged group
Patient no, (site no.) Age (y) Sex Arch c-VDG (mm) c-HDG (mm) r-VOL (ccm)
1 (1) 69 F Mandible 1 4 0.82
2 (2) 62 F Maxilla 6 11 -
3 (3) 67 F Maxilla 2 8 0.96
4 (4) 57 F Maxilla 3 15 -
4 (5) Maxilla 3 10 -
5 (6) 57 F Mandible 5 8 0.89
5 (7) Mandible 9 8 1.48
6 (8) 22 F Maxilla 4 8 1.00
7 (9) 46 F Mandible 6 8 0.87
8 (10) 56 F Mandible 4 7 1.01
9 (11) 42 F Mandible 6 10 0.60
10 (12) 43 M Maxilla 8 7 -
11 (13) 49 F Mandible 4 8 1.88
11 (14) Mandible 6 9 1.81
12 (15) 64 F Mandible 1 7 -
13 (16) 59 F Mandible 4 10 1.49
14 (17) 38 F Mandible 5 8 0.60
15 (18) 60 F Mandible 4 11 0.96
Mean 4.50 8.72 1.11
STDEV 2.15 2.30 0.42
c-VDG clinical vertical dimension change, c-HDG clinical horizontal dimension change, r-VOL radiographic
volume
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and the fact that non-resorbable membranes impair peri-
osteal blood supply of the supracrestal soft tissues.
Following our protocol, the minimally required
keratinized tissue thickness of 2 mm and width of
3 mm was successfully obtained in all cases.
Discussion
The present case series has evaluated the feasibility of a newly
proposed minimally invasive split-thickness flap design with-
out vertical-releasing incisions for vertical bone regeneration
performed in either a simultaneous or staged approach and
also analyzed the prevalence of adverse events during postop-
erative healing. According to the best of our knowledge, this is
the first report demonstrating predictable outcomes following
vertical GBR using a split-thickness flap design.
The present material comprised a total of 24 surgical sites
treated by means of vertical GBR, while hard tissue changes
were assessed by clinical and 3D radiographic evaluation.
Although short implants and horizontal ridge augmentation
using non-resorbable membranes were considered alternative
treatment options, vertical ridge augmentation was carried out
to achieve an optimal implant to crown ratio, thereby mini-
miz ing open in te rprox imal spaces , enhanc ing
cleansability, and esthetics. Edentulous ridges were re-
constructed in order to be leveled off with the adjacent
periodontium of neighboring teeth, thus avoiding or
minimizing negative bone remodeling.
A complicated compromised alveolar defect morphology
often requires three-dimensional reconstructive surgery before
or at the time of implant placement resulting in proper crestal
bone levels with long-term stability around dental im-
plants. The GBR procedure has high efficacy and pre-
dictability and is suitable for both horizontal and verti-
cal ridge reconstructions [28]. However, the literature
related to vertical GBR is very scarce, consisting of
either prospective or retrospective case series.
The number of cases included in the present case series
exceeds those reported in previous studies [16]. In the present
study, 6 sites were treated by simultaneous GBR, while 18
sites received a staged approach. The majority of the patients
were females, presumably with better compliance, with more
health consciousness, and willing to undergo complex thera-
py. All cases were treated using the same split-thickness flap
design, and all implants demonstrated successful
osseointegration. Favorable peri-implant hard tissue surround-
ings were created around 36 out of 36 of the implants treated
with the staged and around 7 out of 9 implants treated with the
simultaneous approach.
Periosteal fenestration and vertical-releasing incisions are
commonly used for vertical GBR to elevate a tensionless flap
[11, 18, 29, 30]. Nevertheless, this flap design often results in
complications such as swelling, bleeding, and patient discom-
fort, as well as flap perforation and graft exfoliation in 2.5–
10% of the cases, depending on the augmentation technique
[19]. One of the main causes behind these complications is
probably the placement of deep periosteal incisions, which
interrupts periosteal blood vessel circulation. Increased tissue
swelling due to postoperative blood stasis generates ten-
sion at the crestal incision line which, in turn, may
compromise wound healing and may lead to premature
membrane exposure [20, 31].
The advantage of the present, prospectively evaluated sur-
gical technique is the possibility of the bilaminar wound clo-
sure and the increased extensibility of the buccal mucosa,
which will lead to a tension-free flap adaptation thus minimiz-
ing postoperative complications related to wound dehis-
cences. Uninterrupted blood supply induces optimal flap re-
vascularization, which predictably results in uneventful early
wound healing and moderate postoperative swelling and
bleeding as well as membrane exposure. In the present study,
only 1 out of 24 surgical sites (4.2%) demonstrated early
membrane exposure, which is lower compared with that in
literature [21, 25, 28, 32–35]. The only patient demonstrating
early membrane exposure displayed one single tooth gap,
where flap mobilization and tension-free wound closure are
technically more challenging, compared with cases involving
larger edentulous sites.
AP can be harvested either extraorally or intraorally and
possesses substantial osteoinductive activity; however, it is
prone to resorption. Particulate xenogeneic bone substitutes
exhibit long-term volume stabil i ty and excellent
osseoconductive capacity. In the present study, the application
of a 1:1 mixture of AP and BDX was chosen, similarly to that
described by Urban and co-workers [36]. This appears to rep-
resent a goldenmean allowing for an optimal balance between
graft remodeling and tissue stability. At reentry, clini-
cally sufficient quality and quantity of newly formed
hard tissues were observed in all cases. This is compa-
rable with the results reported by several other authors
applying 1:1 mixture of AP + BDX [24].
The titanium-reinforced non-resorbable e-PTFEmembrane
as a mechanical barrier is capable of preventing soft tissue
migration and protecting the blood clot to achieve vertical
hard tissue gain. The outer surface of the e-PTFE membrane
has an open microstructure portion, while the inner surface is
completely cell occlusive [37]. Former studies have demon-
strated that the porous size determines regenerative capacity
and clinical handling. Larger porous size could enhance bio-
logical effects; nevertheless, bone-membrane surface contact
is considered to be too high, and therefore, membrane removal
is difficult [38]. Bacterial colonization in case of membrane
exposure could lead to bacterial infection after 4 weeks, which
results in decreased hard tissue formation. In the present study,
we have successfully used a new type of PTFE membrane for
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vertical GBR. The d-PTFE membrane has smaller pores; nev-
ertheless, recent studies proved that the regenerative capacity
is similar to e-PTFE membranes. d-PTFE is suggested for
socket preservation, and staged and simultaneous vertical aug-
mentation [22, 39]. In case of membrane exposure, the d-
PTFE membrane temporarily inhibits biomaterial-centered
bacterial adhesion and infection. Previous studies demonstrat-
ed successful socket preservation with d-PTFE membrane
when left intentionally exposed [40, 41]. In our study, unex-
pected membrane exposure occurred only in one case of the
simultaneous group. Six weeks later, the membrane was re-
moved, and soft tissue ingrowth was observed underneath. A
healing abutment was placed; the implant showed no consid-
erable crestal bone loss at the time of loading.
The amount of newly formed hard tissues is critical to
create a stable environment around implants for long-term
success. The efficacy of augmentation procedures is directly
related to the extent of the newly created peri-implant bony
surroundings. Therefore, accurate standardized evaluation of
vertical and horizontal hard tissue dimensions before and after
augmentation procedures is necessary to judge treatment effi-
cacy. With the recent development in 3D imaging and com-
puter technology, pre- and postoperative linear dimensions
and volumetric changes may be measured and visualized pre-
cisely. Still, the vast majority of data reported in literature is
based on direct clinical measurements only. These assess-
ments rely on the application of several types of probes or
surgical calipers. Moreover, measurement inaccuracy due to
limited visualization and positioning of the registration de-
vices cannot be avoided intraoperatively. According to most
of the relevant publications, vertical and horizontal gains fol-
lowing augmentation procedures are routinely registered at
the utmost extent of reconstructed sites; however, this does
not always represent actual implant positions. Due to the
abovementioned inevitable difficulties, direct clinical mea-
surements cannot be standardized over a large number of in-
terventions. Therefore, we aimed at applying a standardized
radiographic 3D evaluation approach, registering utmost line-
ar and volumetric changes at actual implant positions in the
present study. Cases treated by simultaneous GBR represent-
ed the only exception, since a second CBCT scan could not be
accepted ethically according to the ALARA principles [42].
According to previous studies, 3.6–5.5-mm vertical hard
tissue gain can be obtained after staged 3D GBR procedures
utilizing different grafting materials. In 2003, Artzi and co-
workers could reach 5.2-mm vertical hard tissue gain on av-
erage with titaniummeshes and BDX [25]. In 2004, Roccuzzo
and co-workers used AB covered by titanium meshes, and
reported an average vertical gain of 4.8 mm [43]. In 2005,
Proussaefs and Lozada’s vertical hard tissue gain was
4.8 mm 6 months after GBR, utilizing AP and AP + BDX
without any barrier membranes [44]. Roccuzzo and co-
workers used AB with and without titanium meshes. They
observed a mean of 4.8-mm vertical hard tissue gain in the
titanium mesh group, and a mean 3.6-mm new hard tissue
with blocks alone [44]. In our study, 4.5 ± 2.2 mm was the
average vertical hard tissue gain in the staged group, which
compares well with the previous achievements despite utiliz-
ing AP + BDX only without bone blocks, covered by d-PTFE
membranes. Urban and co-workers found 5.5-mm verti-
cal hard tissue gain following the application of AP +
BDX and d-PTFE membranes, nevertheless, with a con-
ventional full-thickness flap design with vertical and
periosteal releasing incisions [22].
According to the literature, 2.1–5-mm vertical hard tissue
gain can be obtained after simultaneous 3D GBR procedures
utilizing various grafting materials. In 1997, Corrente and co-
workers utilized calcium carbonate and fibronectin sealing
system around dental implants and observed a mean gain of
2.1 mm [45]. Simion and co-workers used e-PTFE mem-
branes with AP or demineralized freeze-dried bone allograft
(DFDBA) particles around implants. The AP group showed
an average of 5 mm; the DFDBA group showed an average of
3.1-mm vertical hard tissue gain [12]. In 2007, Merli and co-
workers applied e-PTFE membranes or resorbable collagen
barriers with osteosynthesis plates for vertical augmentation
at implant placement. The grafting material was AP. In the e-
PTFE group, the mean vertical hard tissue gain was 2.5 mm,
while in the resorbable barrier group, the amount of newly
formed hard tissue measured 2.2 mm [34]. In our present
study, we observed a mean 3.2 ± 1.9 mm vertical hard tissue
gain by combining AP + BDXwith d-PTFEmembranes in the
simultaneous group. Among previous reports, only Simion
and co-workers showed higher vertical hard tissue fill
(5mm), nevertheless by utilizing AP only in combination with
e-PTFE membranes.
The horizontal dimension of vertically augmented sites is
crucial for long-term crestal bone stability. Based on the avail-
able data from the literature, a 1.5–2-mm facial bone width
around dental implants is needed, which practically requires
7–8-mm crestal bone width in the horizontal dimension in
cases of a standard, approximately 4-mm diameter implant
[46–48]. Data reporting on the horizontal hard tissue gain
following vertical GBR is scarce and are available only for
horizontal GBR procedures, which cannot be compared with
the results of the present study. Buser and co-workers mea-
sured the width of the alveolar ridge before and after horizon-
tal GBR and reported an average horizontal hard tissue gain of
3.5 mm [49]. In 2008, Hämmerle and co-workers reported
comparable outcomes, achieving 3.6-mm horizontal hard tis-
sue gain [50]. Wallace and co-workers detected 4.6-mm hor-
izontal hard tissue gain 6 months after horizontal augmenta-
tion with cancellous freeze-dried allograft bone blocks, as
confirmed by CBCT radiographic evaluation [51]. Da Costa
and co-workers applied allogenic bone blocks alone or im-
pregnated with autogenous bone marrow during horizontal
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GBR. Their results have shown a mean horizontal gain of
2.2 mm and 4.6 mm, respectively [52]. In our study, the hor-
izontal hard tissue gain 9 months after vertical GBR averaged
8.7 ± 2.3 mm after staged GBR procedures, and 6.5 ± 0.5 mm
after simultaneous GBR procedures, respectively. From a
clinical point of view, these results may ensure predictable
crestal bone stability which is one of the important criteria
for short- and long-term clinical success.
Conclusions
Within their limits, the present results have shown that staged
and simultaneous vertical reconstruction of deficient alveolar
ridges by means of GBR with titanium-reinforced d-PTFE
membranes combined with a bilaminar split-thickness flap
design delivered predictable hard tissue formation as deter-
mined clinically and radiographically. The used surgical ap-
proach resulted in favorable wound healing, low patient mor-
bidity, and low rate of membrane exposure.
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